CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
2.50
-0.15 (-5.66%)
At close: Jun 02, 2025, 3:59 PM
2.50
-0.20%
After-hours: Jun 02, 2025, 07:58 PM EDT
CytomX Therapeutics Revenue
CytomX Therapeutics reported an annual revenue of $138.1M, reflecting a 36.45% growth. For the quarter ending March 31, 2025, CytomX Therapeutics generated $50.92M in revenue.
Revenue (ttm)
$138.1M
Revenue Growth
36.45%
Price / Sales Ratio
0.63
Revenue / Employee
$1.16M
Employees
119
Market Cap
394.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|